
Sign up to save your podcasts
Or


In this episode of Bundy Group Insights, Managing Directors Clint Bundy and Drew Thomas bring together two seasoned acquirors in the dermatology and medical aesthetics market: Darcie Surinak, President of AYA Medical Spa, and Evan Heflin, Principal at Gryphon Investors. Both guests offer unique and practical perspectives on the current transaction landscape, what drives valuations, and the characteristics that differentiate high-performing dermatology practices and medical spa platforms.
Together, they explore the rapidly evolving market dynamics in aesthetics and dermatology, including how private equity continues to shape deal structures, competitive tension, and long-term value creation. The conversation dives into operational excellence, leadership continuity, scalability, and the metrics buyers prioritize when evaluating potential acquisitions. Listeners will gain a clearer understanding of how sophisticated strategic buyers and growth-focused private equity groups approach the sector—and what practice owners can do today to prepare for a successful M&A process and maximize long-term enterprise value.
What You'll Learn in This Episode:
This episode offers actionable insights for:
Whether you're contemplating a near-term exit or planning long-term growth, this roundtable provides a grounded look into what truly drives buyer interest and value in today's dermatology and aesthetics marketplace.
ℹ️ Learn more about Bundy Group by visiting https://bundygroup.com.
By Bundy GroupIn this episode of Bundy Group Insights, Managing Directors Clint Bundy and Drew Thomas bring together two seasoned acquirors in the dermatology and medical aesthetics market: Darcie Surinak, President of AYA Medical Spa, and Evan Heflin, Principal at Gryphon Investors. Both guests offer unique and practical perspectives on the current transaction landscape, what drives valuations, and the characteristics that differentiate high-performing dermatology practices and medical spa platforms.
Together, they explore the rapidly evolving market dynamics in aesthetics and dermatology, including how private equity continues to shape deal structures, competitive tension, and long-term value creation. The conversation dives into operational excellence, leadership continuity, scalability, and the metrics buyers prioritize when evaluating potential acquisitions. Listeners will gain a clearer understanding of how sophisticated strategic buyers and growth-focused private equity groups approach the sector—and what practice owners can do today to prepare for a successful M&A process and maximize long-term enterprise value.
What You'll Learn in This Episode:
This episode offers actionable insights for:
Whether you're contemplating a near-term exit or planning long-term growth, this roundtable provides a grounded look into what truly drives buyer interest and value in today's dermatology and aesthetics marketplace.
ℹ️ Learn more about Bundy Group by visiting https://bundygroup.com.